Alessandro Sanitin/LinkedIn
Apr 7, 2026, 13:50
Alessandro Santin Discusses New Targets in Rare Endometrial Disease – Yale Obstetrics, Gynecology and Reproductive Sciences
Yale Obstetrics, Gynecology and Reproductive Sciences shared a post on LinkedIn:
” ‘It’s only when you acquire the type of deep knowledge in the molecular characteristic that you may really identify potential targets,’ says our own Yale Ob/Gyn’s Alessandro Sanitin, MD.
In an interview with Contemporary OB/GYN, Dr. Santin discusses his investigation of new treatments for rare endometrial disease.
Read and/or listen here.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Nov 12, 2026, 18:26Jakub Dejewski: IVF Turns 49, We’re Making It with 49 More Families
-
Nov 12, 2026, 18:16Svitlana Popkova: What IVF Should Feel Like
-
Nov 12, 2026, 18:10Caspian Ostadian: How Long Should an Embryo Rest After Warming Before Transfer?
-
Nov 12, 2026, 18:03Fereshteh Safian: Pleased to Participate in the 24th International Congress of the Iranian Society for Reproductive Medicine
-
Nov 12, 2026, 17:54Zuzana Holubcova: Assisted Reproduction Community Comes Together at 36th Congress
-
Nov 12, 2026, 17:47Mark Amols: 3 Trials, 3 Different Patients – IUI or IVF First?
-
Nov 12, 2026, 17:44Nearly 1 in 5 Women Surveyed Have Experienced Infertility – IVI Institute
-
Nov 12, 2026, 17:40Kate Ryder: Maven Care Is Now In-Network with More Than 475 Health Plans
-
Nov 12, 2026, 17:37Diana Kayal: Speaking About Trauma and Fertility at the 3rd International Conference on Gynecology and Women’s Health
